Japanese Personal Products Stock News

As global markets navigate a period of mixed economic signals and sector rotations, Asian equities have shown resilience, particularly in the manufacturing and financial sectors. In this environment, dividend stocks can offer investors a stable income stream while potentially benefiting from Asia's ongoing economic developments.

Japan’s rate market has swung sharply back into focus, with the 10 year government bond yield hitting 2.88% and renewed concern over inflation, oil prices, and heavy fiscal spending. For investors, this mix of higher yields and inflation risk can quietly reshape which stocks look resilient and which ones may struggle. This article looks at three stocks exposed to the latest news on Japanese rates and inflation pressures, all on the risk side of the ledger, to help you spot where rising...

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Japan’s 10-year bond yield sitting at 2.825%, the highest level since 1996, is forcing investors to rethink how to position around domestic financial stocks. With the Bank of Japan trimming its bond purchases, heavier government bond issuance ahead, a weak yen and pressure on crowded yen carry trades, the ripple effects across banks and insurance companies could be significant. This article focuses on how these shifts may affect Japanese financials and highlights 3 stocks from our Domestic...

As of July 2026, the Asian markets are navigating a complex landscape marked by mixed returns in major indices and evolving economic indicators. With China's manufacturing activity showing resilience and Japan's business sentiment improving, investors are keenly observing small-cap opportunities that may thrive amid these broader market dynamics. In this context, identifying stocks with strong fundamentals and growth potential becomes crucial for those seeking to capitalize on Asia's diverse...

Japan’s sovereign debt stress is back in focus as 10‑year government bond yields touch 2.87% and questions build around a $2.3tn spending plan. For investors, that combination of higher yields, a weaker yen and concern about long term fiscal sustainability can reshape the risk profile of Japan’s financial sector. Some stocks may be positioned to benefit, but others face pressure as funding costs and bond market volatility bite. This article looks at 3 Japanese financial stocks that appear...

Ecowende announced that its 760MW Hollandse Kust West offshore wind farm in the Netherlands, developed by a joint venture including Chubu Electric Power, has been connected to TenneT's offshore grid and has already delivered its first green electricity. This milestone highlights Chubu Electric Power's growing participation in large-scale international renewable projects, underlining its role in the broader energy transition. With the Hollandse Kust West project now feeding power into the...

Ono Pharmaceutical (TSE:4528) moved sharply on the back of regulatory progress for Opdivo, pipeline updates around Velexbru and Qinlock, and encouraging mid stage trial data that reinforced interest in its cancer and rare disease portfolio. See our latest analysis for Ono Pharmaceutical. Against this backdrop, Ono Pharmaceutical’s share price has a 10.5% 1 month share price return and a 12.3% year to date share price return, while its 1 year total shareholder return of 65.0% points to strong...

Key earnings guidance figures investors are watching BANDAI NAMCO Holdings (TSE:7832) recently issued new earnings guidance, outlining expectations for the six months ending September 30, 2026, and the full fiscal year ending March 31, 2027, giving investors fresh visibility on projected results. For the first half of the fiscal year, the company is guiding to net sales of ¥610,000 million, operating profit of ¥84,000 million, profit attributable to owners of parent of ¥60,000 million, and...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Sanrio Company recently reported full-year results for the year ended March 31, 2026, with sales of ¥194,088,000,000 and net income of ¥54,608,000,000, alongside a dividend of ¥38.00 per share for that year, up from ¥33.00 previously. The company also issued guidance for the year to March 31, 2027, pointing to higher expected sales and profit, while at the same time flagging a significantly lower dividend of ¥8.00 per share, a combination that may prompt investors to reassess how it is...

Japanese financial institutions are sitting at the crossroads of a weak yen, wide interest rate gaps with the U.S., and the possibility of government intervention in currency markets. For investors watching the Japanese yen sit near a multi decade low, this mix of forces could create both pressure and opportunity across banks and insurers. This article focuses on three Japanese Financial Institutions screener stocks that appear strongly tied to these themes, and explains how currency swings...

Tsubakimoto Chain (TSE:6371) has completed a share buyback program, repurchasing 2,399,000 shares, or 2.31% of its stock, for ¥6,203.81 million. This action can reshape per share metrics and ownership dynamics. See our latest analysis for Tsubakimoto Chain. Alongside the completed buyback, Tsubakimoto Chain’s share price has risen 14.06% year to date. The 1 year total shareholder return of 51.63% and 5 year total shareholder return of 188.91% point to building momentum. If this buyback has...

As global markets navigate a mix of economic signals, with the U.S. labor market showing signs of cooling and China's manufacturing sector exhibiting resilience, investors are increasingly attuned to the nuanced dynamics within Asian markets. In this context, identifying promising stocks often involves seeking companies that demonstrate robust fundamentals and adaptability in a shifting economic landscape.

China’s latest export controls on Japanese defense and technology companies have pushed supply chain security and rare earth independence back into the spotlight. For investors, this kind of shock can quickly reshape how risk and opportunity are priced across Japanese stocks exposed to the news. This article breaks down what the policy shift might mean for larger domestic supply chain players, and why some of them could see changing expectations around their role in Japan’s push for...

DCM Holdings earnings event and what it means for investors DCM Holdings (TSE:3050) has drawn fresh attention after reporting first quarter results to May 31, 2026, with sales of ¥151,942 million and net income of ¥6,558 million, both higher than a year earlier. See our latest analysis for DCM Holdings. Despite the stronger first quarter figures, DCM Holdings’ recent share price performance has been mixed. The 1-day share price return was 1.01%, but the 90-day share price return declined...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Sompo Holdings (TSE:8630) is back in focus after the company reported progress on its open market share repurchase program, including completion of a ¥9.75b tranche. This has sharpened attention on its capital allocation plans. See our latest analysis for Sompo Holdings. The share buyback update comes after a strong run in Sompo Holdings' stock, with a 1 month share price return of 14.78% and a year to date share price return of 24.63%, alongside a 1 year total shareholder return of 65.55%...

While TOKYO KEIKI INC. ( TSE:7721 ) might not have the largest market cap around , it received a lot of attention from...

Daiichi Sankyo and AstraZeneca recently secured a European Commission approval for Enhertu across multiple HER2 positive metastatic solid tumors and received an EMA committee recommendation for Datroway as first-line treatment for certain triple-negative breast cancer patients, alongside board decisions on share-based compensation. These oncology milestones expand Daiichi Sankyo’s European treatment footprint, trigger a US$25 million milestone payment from AstraZeneca, and reinforce the...

Oracle Corporation Japan (TSE:4716) updated investors with new guidance for the year ending May 31, 2027, alongside an increase in its regular dividend and a sizeable special dividend that highlight current shareholder returns. See our latest analysis for Oracle Corporation Japan. At a share price of ¥8,826, Oracle Corporation Japan has recently gained ground with a 1-day share price return of 0.91% and a 7-day share price return of 3.65%. However, the share price return is still down 30.37%...

Terumo Interventional Systems recently completed the first U.S. procedure using its OPUSWAVE Dual Sensor Imaging System at Mount Sinai Fuster Heart Hospital, combining Optical Frequency Domain Imaging and intravascular ultrasound in a single catheter to enhance intravascular imaging for coronary interventions. This dual-modality platform directly targets physicians’ demand for clearer, real-time vessel visualization and procedural confidence, potentially strengthening Terumo’s position in...

ASKUL (TSE:2678) has just posted its FY 2026 numbers, with fourth quarter revenue of ¥113.3b and a basic EPS loss of ¥90.78, capping a trailing twelve month picture that shows revenue of ¥400.2b and a full year EPS loss of ¥245.40. Over recent periods, the company has seen quarterly revenue move from ¥122.3b in Q4 FY 2025 to ¥113.3b in Q4 FY 2026, while quarterly basic EPS shifted from ¥31.42 to a loss of ¥90.78, underscoring a clear hit to profitability. For investors, these results put...

Investors in Kusuri No Aoki Holdings Co., Ltd. ( TSE:3549 ) had a good week, as its shares rose 5.8% to close at...